The ACP received funding to help interpret research and support decisions about MS treatments for older adults with MS.

A novel program provided evidence that addressing long-known disparities in high-efficacy multiple sclerosis (MS) treatment for minority populations is a solvable problem. The program, presented by ...

IMP761 was well tolerated in healthy volunteers when given at single increasing doses, with no safety concerns, according to ...

For the last 20 years, people have been coming together across the Capital Region to support the National MS Society, while ...

Grace Miller was a 24-year-old law school student when she was diagnosed with multiple sclerosis ...

As recently as the ‘90s, when patients arrived with all the typical symptoms — memory loss, double vision, fatigue — neurologists often avoided confirming what they most suspected: that the patient ...

Should multiple sclerosis (MS) patients stop disease-modifying treatment (DMT) as they get older? The answer depends on several factors, noted John Corboy, MD, of the Rocky Mountain MS Center at the ...

NEW YORK, NY, UNITED STATES, March 24, 2026 /EINPresswire.com/ — Scientists at the Tisch Multiple Sclerosis Research Center ...

PARIS — The first real guidelines on the use of disease-modifying therapies in multiple sclerosis (MS) have been released by a European joint venture between the European Committee for Research and ...

He revealed more recently he had bio-cellular therapy treatment on his spine Kevin Winter/Getty Jack Osbourne is opening up about his Multiple Sclerosis (MS) diagnosis. The 38-year-old media ...

Multiple sclerosis prevalence has increased by 6% annually, reaching an estimated 190,000 cases today. New research ...